John Evans
Directeur Général chez BEAM THERAPEUTICS INC.
Fortune : 25 M $ au 30/04/2024
Profil
Actuellement, John Evans occupe le poste de directeur général et de directeur de Beam Therapeutics, Inc. et de partenaire de risque chez ARCH Venture Partners LLC. M. Evans est également membre du conseil d'administration de Verve Therapeutics, Inc. Il a précédemment occupé le poste de vice-président chargé du développement commercial et des opérations chez Agios Pharmaceuticals, Inc. et celui de responsable des relations avec les investisseurs chez Infinity Pharmaceuticals, Inc. M. Evans a obtenu un diplôme d'études supérieures de l'université de Pennsylvanie, un diplôme de premier cycle de l'université de Yale et un MBA de la Wharton School de l'université de Pennsylvanie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
1,42% | 03/04/2024 | 1 161 343 ( 1,42% ) | 25 M $ | 30/04/2024 |
Postes actifs de John Evans
| Sociétés | Poste | Début |
|---|---|---|
| BEAM THERAPEUTICS INC. | Directeur Général | 01/01/2017 |
Blink Therapeutics, Inc.
 Blink Therapeutics, Inc. BiotechnologyHealth Technology Part of Beam Therapeutics, Inc., Blink Therapeutics, Inc. develops a novel platform to generate therapeutic and diagnostic monoclonal antibodies. The company is based in Wilmington, DE. The CEO of the company is John Evans. | Directeur Général | - |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Directeur/Membre du Conseil | - |
Anciens postes connus de John Evans
| Sociétés | Poste | Fin |
|---|---|---|
| PRIME MEDICINE, INC. | Directeur/Membre du Conseil | 13/09/2022 |
| VERVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/08/2022 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 31/03/2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/07/2006 |
Formation de John Evans
| University of Pennsylvania | Graduate Degree |
| Yale University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| VERVE THERAPEUTICS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Part of Beam Therapeutics, Inc., Blink Therapeutics, Inc. develops a novel platform to generate therapeutic and diagnostic monoclonal antibodies. The company is based in Wilmington, DE. The CEO of the company is John Evans. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Health Technology |